Grant: CIHR Fellowship
Direct Payment
$150,000.00
Microparticles as Mediators of Inflammation
FY 2009-10
Summary
Rheumatoid arthritis (RA) is a serious chronic disease affecting 1-2% of the population. Patients with this condition develop inflammation and damage of the joints, leading to pain, disability and loss of productivity. While advances in therapy have improved outcomes, many patients still do not respond adequately to existing treatments which can be associated with side effects such as susceptibility to infection. In this study, I will address a new mechanism by which we believe inflammation in RA develops. Normally, cellular components are safely contained by several sets of membranes, but when released to the outside of the cell, can contribute to inflammation. My theory is that small pieces of cells, called microparticles (MPs), which are released either when cells die or become activated by the immune system, are a vehicle for this troublesome cellular component release. To support this, many studies have shown higher numbers of MPs in the blood of patients suffering a wide variety of diseases, including RA. To advance existing knowledge I plan to study the release of MPs from macrophage cells, which line the joints and are thus very relevant to patients suffering from RA. I plan to stimulate macrophage cells with various immune molecules to test my theory that MPs are the source of extracellular nucleic acids, ultimately causing inflammation. I will measure DNA and RNA in these particles as well as analyze other molecules related to their release. I will also study internal signaling pathways controlling MP release, in particular those that involve nitric oxide. Overall, my goal is to determine the potential for MPs as a source of RA inflammation, which is thus far largely unknown. As such, this innovative research program, which aims to understand causes of RA, will hopefully lead to new ideas for therapeutic targets so that new drugs can be developed to help those who suffer from this chronic disease.
Department
Program
CIHR Fellowship
Recipient
Location
North Carolina, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
193451
Name
Gauley Julie L
Region
North Carolina
Country
United States of America
Orgtype
Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Microparticles as Mediators of Inflammation
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Apoptosis; Autoimmunity; Cytokines; Macrophages; Microparticles; Nitric Oxide; Nucleic Acids; Toll-Like Receptors
Abstract
Rheumatoid arthritis (RA) is a serious chronic disease affecting 1-2% of the population. Patients with this condition develop inflammation and damage of the joints, leading to pain, disability and loss of productivity. While advances in therapy have improved outcomes, many patients still do not respond adequately to existing treatments which can be associated with side effects such as susceptibility to infection. In this study, I will address a new mechanism by which we believe inflammation in RA develops. Normally, cellular components are safely contained by several sets of membranes, but when released to the outside of the cell, can contribute to inflammation. My theory is that small pieces of cells, called microparticles (MPs), which are released either when cells die or become activated by the immune system, are a vehicle for this troublesome cellular component release. To support this, many studies have shown higher numbers of MPs in the blood of patients suffering a wide variety of diseases, including RA. To advance existing knowledge I plan to study the release of MPs from macrophage cells, which line the joints and are thus very relevant to patients suffering from RA. I plan to stimulate macrophage cells with various immune molecules to test my theory that MPs are the source of extracellular nucleic acids, ultimately causing inflammation. I will measure DNA and RNA in these particles as well as analyze other molecules related to their release. I will also study internal signaling pathways controlling MP release, in particular those that involve nitric oxide. Overall, my goal is to determine the potential for MPs as a source of RA inflammation, which is thus far largely unknown. As such, this innovative research program, which aims to understand causes of RA, will hopefully lead to new ideas for therapeutic targets so that new drugs can be developed to help those who suffer from this chronic disease.
Competitiondate
200910
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Gauley, Julie L
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~